Richard J. Austin

1.8k citations

22 papers · 1.4k indexed · h-index 14

Co-authors: Stephen P. Bell Terry L. Orr‐Weaver Mark D. Biggin Giovanni Bosco Irena Royzman Timothy Hoey Vincent Archambault Gwendolyn M. Wilmes
Topics: CAR-T cell therapy research (5 papers)Genomics and Chromatin Dynamics (5 papers)Monoclonal and Polyclonal Antibodies Research (4 papers)
Cited by: Molecular Biology Cell Biology Oncology
Journals: Cell Proceedings of the National Academy of Sciences Neuron
Partner nations: United States United Kingdom Germany

In The Last Decade

Richard J. Austin

22 papers receiving 1.4k citations

Peers

Countries citing papers authored by Richard J. Austin

Since Specialization

Citations

This map shows the geographic impact of Richard J. Austin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Austin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Austin more than expected).

Fields of papers citing papers by Richard J. Austin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard J. Austin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Austin. The network helps show where Richard J. Austin may publish in the future.

Co-authorship network of co-authors of Richard J. Austin

This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. Austin. A scholar is included among the top collaborators of Richard J. Austin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. Austin. Richard J. Austin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 913: FLT3-targeting TriTACs are T cell engagers for treatment of acute myeloid leukemia 2021 ·Cancer Research ·Richard J. Austin,Wade H. Aaron,(unknown),(unknown),(unknown),Golzar Hemmati,Che‐Leung Law,Bryan D. Lemon,(unknown),(unknown),Morgan N. Thompson,(unknown),Holger Wesche,Kevin J. Wright,Yinghua Xiao,Stephen Yu,Timothy Z. Yu	1
2	Preclinical Characterization of HPN536, a Trispecific, T-Cell–Activating Protein Construct for the Treatment of Mesothelin-Expressing Solid Tumors 2020 ·Clinical Cancer Research ·(unknown),Richard J. Austin,Bryan D. Lemon,Wade H. Aaron,(unknown),(unknown),Susan Dana Jones,(unknown),(unknown),Kenneth G. Sexton,(unknown),Timothy Z. Yu,Patrick A. Baeuerle,Che‐Leung Law,Holger Wesche	35
3	First-in-human phase I study of HPN424, a tri-specific half-life extended PSMA-targeting T-cell engager in patients with metastatic castration-resistant prostate cancer (mCRPC). 2020 ·Journal of Clinical Oncology ·Johanna C. Bendell,Lawrence Fong,Mark N. Stein,Tomasz M. Beer,Ashley E. Ross,Xīn Gào,Aaron Weitzman,Richard J. Austin,(unknown),Che‐Leung Law,Bryan D. Lemon,Holger Wesche,Johann S. de Bono	12
4	Abstract 1773: HPN424, a half-life extended, PSMA/CD3-specific TriTAC for the treatment of metastatic prostate cancer 2018 ·Cancer Research ·Bryan D. Lemon,Wade H. Aaron,Richard J. Austin,Patrick A. Baeuerle,(unknown),(unknown),Susan Dana Jones,(unknown),Che‐Leung Law,(unknown),Kenneth G. Sexton,(unknown),Holger Wesche,Timothy Z. Yu	6
5	Abstract 1781: HPN536, a T cell-engaging, mesothelin/CD3-specific TriTAC for the treatment of solid tumors 2018 ·Cancer Research ·Richard J. Austin,Wade H. Aaron,Patrick A. Baeuerle,(unknown),(unknown),Susan Dana Jones,Che‐Leung Law,(unknown),Bryan D. Lemon,(unknown),Kenneth G. Sexton,(unknown),Holger Wesche,Timothy Z. Yu	7
6	Abstract 3814: TriTACs are novel T cell-engaging therapeutic proteins optimized for the treatment of solid tumors and for long serum half-life 2018 ·Cancer Research ·Holger Wesche,Wade H. Aaron,Richard J. Austin,Patrick A. Baeuerle,(unknown),Bryan D. Lemon,Kenneth G. Sexton,Timothy Z. Yu	5
7	Discovery of GW870086: a potent anti‐inflammatory steroid with a unique pharmacological profile 2013 ·British Journal of Pharmacology ·Iain Uings,(unknown),J. L. Matthews,(unknown),Richard J. Austin,(unknown),(unknown),J T Holt,Keith Biggadike,Stuart Farrow	24
8	Addressing PXR liabilities of phthalazine-based hedgehog/smoothened antagonists using novel pyridopyridazines 2010 ·Bioorganic & Medicinal Chemistry Letters ·Jacob A. Kaizerman,Wade H. Aaron,Songzhu An,Richard J. Austin,Matthew A. Brown,(unknown),Tom Huang,Randall W. Hungate,(unknown),Michael G. Johnson,Gary Lee,Brian S. Lucas,Jessica Orf,Minqing Rong,Maria M. Toteva,Dineli Wickramasinghe,Guifen Xu,Qiuping Ye,Wendy Zhong,Dustin L. McMinn	20
9	Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers 2005 ·Biochemical Journal ·Sylvia Herter,Derek E. Piper,Wade H. Aaron,(unknown),Gene Cutler,Ping Cao,Ami S. Bhatt,Youngchool Choe,Charles S. Craik,Nigel P.C. Walker,David Meininger,Timothy Hoey,Richard J. Austin	152
10	Interaction of the S-phase cyclin Clb5 with an 'RXL' docking sequence in the initiator protein Orc6 provides an origin-localized replication control switch 2004 ·Genes & Development ·Gwendolyn M. Wilmes,Vincent Archambault,Richard J. Austin,(unknown),Stephen P. Bell,Frederick R. Cross	113
11	Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23 2002 ·Nature Genetics ·Jing Li,Ying Yang,Peng Yue,Richard J. Austin,(unknown),Ken Nguyen,Tim Gabriele,Mila E. McCurrach,Jeffrey R. Marks,Timothy Hoey,Scott W. Lowe,Scott Powers	207
12	Mometasone furoate is a less specific glucocorticoid than fluticasone propionate 2002 ·European Respiratory Journal ·Richard J. Austin,Barbara Maschera,Ann C. Walker,(unknown),(unknown),Stuart Farrow,Iain Uings	31
13	Drosophila ORC specifically binds to ACE3, an origin of DNA replication control element 1999 ·Genes & Development ·Richard J. Austin,Terry L. Orr‐Weaver,Stephen P. Bell	167
14	latheo Encodes a Subunit of the Origin Recognition Complex and Disrupts Neuronal Proliferation and Adult Olfactory Memory When Mutant 1999 ·Neuron ·Shirly Pinto,David G. Quintana,Patrick Smith,Robert Mihalek,(unknown),(unknown),Christopher J. Jones,Marvin Hendricks,Klara Velinzon,James A. Wohlschlegel,Richard J. Austin,William S. Lane,Tim Tully,Anindya Dutta	92
15	ORC localization in Drosophila follicle cells and the effects of mutations in dE2F and dDP 1999 ·Genes & Development ·Irena Royzman,Richard J. Austin,Giovanni Bosco,Stephen P. Bell,Terry L. Orr‐Weaver	160
16	Coordinate Binding of ATP and Origin DNA Regulates the ATPase Activity of the Origin Recognition Complex 1997 ·Cell ·(unknown),Richard J. Austin,Stephen P. Bell	209
17	Purification of the Drosophila RNA polymerase II general transcription factors. 1996 ·Proceedings of the National Academy of Sciences ·Richard J. Austin,Mark D. Biggin	24
18	A Domain of the even-skipped Protein Represses Transcription by Preventing TFIID Binding to a Promoter: Repression by Cooperative Blocking 1995 ·Molecular and Cellular Biology ·Richard J. Austin,Mark D. Biggin	46
19	Asynchronous multiple birth. A report of five cases. 1994 ·PubMed ·J. Patrick Lavery,Richard J. Austin,(unknown),Silvio Aladjem	13
20	Cooperative Binding at a Distance by even-skipped Protein Correlates with Repression and Suggests a Mechanism of Silencing 1993 ·Molecular and Cellular Biology ·(unknown),Richard J. Austin,(unknown),Mark D. Biggin	54

About Richard J. Austin

Richard J. Austin is a scholar working on Oncology, Clinical Biochemistry and Behavioral Neuroscience, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Genomics and Chromatin Dynamics (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Molecular Biology (1.1k citations), Cell Biology (257 citations) and Oncology (340 citations). Richard J. Austin has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Stephen P. Bell, Terry L. Orr‐Weaver, Mark D. Biggin, Giovanni Bosco, Irena Royzman, Timothy Hoey, Vincent Archambault, Gwendolyn M. Wilmes, Frederick R. Cross and Ken Nguyen. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Neuron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact